Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Hampshire for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Hampshire only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Hampshire (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ahad Fazelat (NPI 1013141597)

Field	Value
Entity Type	Individual
Organization	Ahad Fazelat
Address	250 River Rd
City	Manchester
State	NH
ZIP	03104
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 12, 2009

Payer Source	Total Paid
Medicare	$2.1M
Medicaid	$0

Key Findings

This provider reports $2.1M in total Medicare revenue and has no Medicaid billing on file, so the practice is effectively single-payer from a claims volume perspective. The precomputed concentration metric indicates the top 3 Medicare codes account for 83.7% of Medicare revenue, signaling a very narrow revenue base dependent on a few services.

Clinical service mix is strongly retina-focused: the highest-revenue codes are J2777, J0178, and J2778, which represent intravitreal anti‑VEGF injections and together drive the majority of billings. Supporting procedure and imaging codes such as 67028 (intravitreal injection), 92134 (retinal imaging), and 92250 (fundus photography) appear in the top codes list, consistent with a practice organized around medical retina care and high-volume injection clinics.

Revenue concentration is especially pronounced on J2777, which alone accounts for $1.2M or 55.4% of the provider’s Medicare revenue, with J0178 ($440.4K, 20.8%) and J2778 ($158.2K, 7.5%) completing the top three; the dataset explicitly reports the top three codes make up 83.7% of Medicare revenues. This concentration indicates the provider’s financial performance is highly sensitive to utilization and reimbursement for these specific injectable therapies.

Competitive standing on the primary drug code is mixed: J2777 is ranked #166 of 2039 nationally (92th percentile) but is labeled in the dataset as a "typical, unremarkable volume for this code," which suggests the provider sits toward the higher end of national volume for faricimab without being an extreme outlier. By contrast, J0178 ranks #1720 of 3204 (46th percentile) and J2778 ranks #487 of 1208 (60th percentile), both described as "typical, unremarkable volume," indicating more modest standing on alternative anti‑VEGF agents relative to peers.

Several non-drug codes show above-typical or outlier activity that characterize clinic operations: 92250 (fundus photography) ranks in the 98th percentile and is labeled an "extreme outlier, far above typical national volume for this code," while 99214 (#13082 of 479517, 97th percentile) and 99204 (#4478 of 227068, 98th percentile) are described as "notably above typical national volume." Together these signals point to unusually high imaging throughput and above-average E/M visit volume for both new and established patients.

The absence of any Medicaid billing on file indicates the provider has either minimal engagement with Medicaid patients or is not billing Medicaid; this creates a concentrated payer mix dominated by Medicare ($2.1M) and may affect network negotiations, access considerations, and revenue stability if Medicare policies change. Analysts should treat the provider as effectively single‑payer for Medicaid-related assessments.

Tenure data show the NPI was enumerated on 2009-05-12 (~17 years ago), indicating the provider has an established presence in the market and likely a stable referral and reimbursement history. That longevity, combined with the high reliance on procedural and imaging codes, suggests an established practice model focused on continuity care for retina patients.

From a risk and business-development perspective, reliance on a small set of high-cost injectable codes (notably J2777 at $1.2M and 55.4% of Medicare revenue) concentrates both revenue opportunity and exposure to changes in drug utilization, FDA labeling, or Medicare payment policy. The provider’s strong imaging and E/M volumes (including the 92250 "extreme outlier" designation) offer potential levers for diversification, but any forecasting or contracting work should explicitly account for the 83.7% top‑3 code revenue concentration reported in the dataset.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

12 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	40,380	$30	$1.2M
J0178	Injection, aflibercept, 1 mg	640	$690	$440.4K
J2778	Injection, ranibizumab, 0.1 mg	860	$180	$158.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,370	$100	$134K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	950	$90	$87.1K
J9035	Injection, bevacizumab, 10 mg	500	$50	$26.4K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	210	$120	$24.4K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	360	$70	$23.5K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	810	$30	$22.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	620	$30	$19.1K

Showing 1–10 of 12

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Hampshire Distribution

Ahad Fazelat — 6 of 12 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Hampshire

Full comparison — all codes billed, vs. state median

12 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2777	3	10	13,440	$30	$563.5K
J0178	5	10	590	$680	$549.1K
J2778	2	10	1,120	$180	$204.1K
67028	3	20	600	$90	$67K
99214	30	3,150	110	$80	$13.2K
J9035	1	10	150	$50	$10.6K
99213	189	2,900	70	$50	$6.9K
92134	9	170	60	$30	$5.2K
99204	6	1,340	30	$100	$4.6K
92250	3	170	80	$30	$3.5K

Showing 1–10 of 12

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ahad Fazelat, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Elliot Professional Services	NH	Internal Medicine Physician	$0	$12.8M
Maxwell Elia	NH	Ophthalmology Physician	$2.3M	$0
Anthony Correnti	NH	Ophthalmology Physician	$1.5M	$0
Gina Divenuti	NH	Hematology & Oncology Physician	$1M	$0
Eliot Foley	NH	Retina Specialist (Ophthalmology) Physician	$935.8K	$0
Frederick Briccetti	NH	Hematology & Oncology Physician	$861.3K	$0
Neal Adams	MD	Ophthalmology Physician	$497.9K	$5.3K
Josy Mathew	NH	Hematology & Oncology Physician	$452.4K	$0
Anthony Squillaro	NJ	Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician	$415.6K	$0
Peter Crow	NH	Hematology & Oncology Physician	$415.1K	$0

Nearby Providers

Other providers in the same ZIP code as Ahad Fazelat, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Interim Healthcare Of The Neast, LLC	NH	Home Health Agency	$0	$32.6M
Carepoint Plus LLC	NH	Home Health Agency	$0	$19.2M
Home Base Collaborative Family Counseling	NH	Clinical Social Worker	$0	$18.2M
Summit New Hampshire LLC	NH	Physical Disabilities Residential Treatment Facility	$0	$11.8M
Interim Healthcare Of The Neast, LLC	NH	Home Health Agency	$0	$4.5M
Ofemz Home Healthcare Agency, LLC	NH	Home Health Agency	$0	$2.5M
Masonic Home	NH	Assisted Living Facility	$0	$2.4M
Bio-medical Applications Of Manchester, Inc.	NH	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$2.3M
Hanover Street Family Dental	NH	General Practice Dentistry	$0	$1.5M
Webster House	NH	Emotionally Disturbed Childrens' Residential Treatment Facility	$0	$1.4M

Ahad Fazelat — Billing Profile & Reimbursement Data

Sign up for Ahad Fazelat — Billing Profile & Reimbursement Data policy alerts

Ahad Fazelat — Billing Profile & Reimbursement Data

Sign up for Ahad Fazelat — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References